Vigabatrin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Vigabatrin and local guidelines before prescribing.

Anticonvulsant

Mechanism

Irreversibly inhibits GABA transaminase.

Uses

Refractory focal epilepsy, infantile spasms.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Visual field defects (often permanent), drowsiness, depression, weight gain.

Interactions

Phenytoin levels fall.

Contraindications and cautions

Visual field defect, psychosis

Monitoring

Visual fields

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Reduce dose if CrCl below 60

Overdose and reversal

Supportive

Special advice

Visual field monitoring; use specialist guidance; avoid if prior visual field defect.

More from the textbook: uses, cautions and other points
Where it is discussed in the book